Cardinal Health Inc. (CAH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Cardinal Health Inc.

NYSE: CAH · Real-Time Price · USD
154.46
-4.00 (-2.52%)
At close: Oct 03, 2025, 3:59 PM
154.69
0.15%
After-hours: Oct 03, 2025, 06:07 PM EDT

Cardinal Health Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
222.58B 222.13B 222.12B 224.29B 226.67B 220.41B 216.03B 210.06B 205.01B 198.66B 193.01B 187B 181.36B 176.85B 171.29B 167.37B 162.47B 156.57B 156.45B 154.65B
Cost of Revenue
214.41B 214.31B 214.49B 216.75B 219.28B 213.05B 208.82B 203.04B 198.12B 192B 186.45B 180.48B 174.82B 170.43B 164.74B 160.66B 155.69B 149.68B 149.49B 147.74B
Gross Profit
8.17B 7.82B 7.63B 7.54B 7.38B 7.35B 7.2B 7.02B 6.89B 6.67B 6.56B 6.52B 6.54B 6.42B 6.54B 6.71B 6.78B 6.89B 6.97B 6.9B
Operating Income
2.27B 2.25B 1.89B 1.85B 1.25B 979M 1.18B 558M 727M 626M -43M -874M -596M -470M 100M 1.51B 472M 580M 669M 542M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.1B 2.11B 1.79B 1.79B 1.21B 931M 1.13B 484M 638M 489M -192M -1.03B -769M -622M -45M 1.35B 323M 1.02B 1.06B 909M
Net Income
1.56B 1.56B 1.31B 1.28B 853M 553M 637M 139M 261M 463M -1.27B -1.09B -932M -954M 555M 1.14B 611M 1.15B 1.38B 973M
Selling & General & Admin
5.38B 5.14B 5.09B 5.05B 4.96B 4.99B 4.9B 4.82B 4.83B 4.72B 4.68B 4.64B 4.56B 4.53B 4.51B 4.51B 4.53B 4.54B 4.59B 4.6B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
511M 428M 647M 642M 1.17B 1.39B 1.13B 1.64B 1.33B 1.32B 1.93B 2.75B 2.58B 2.35B 1.93B 684M 1.77B 1.77B 1.71B 1.76B
Operating Expenses
5.89B 5.56B 5.74B 5.69B 6.13B 6.38B 6.03B 6.46B 6.16B 6.04B 6.61B 7.39B 7.14B 6.88B 6.45B 5.19B 6.31B 6.31B 6.3B 6.36B
Interest Expense
215M 145M 99M 67M 46M 57M 57M 79M 93M 112M 122M 134M 149M 159M 166M 175M 180M 185M 200M 217M
Selling & Marketing Expenses
5.38B 5.14B 3.82B 2.52B 1.24B 1.27B 2.45B 3.64B 4.83B 4.72B 4.68B 4.64B 4.56B 3.4B 3.38B 3.38B 3.4B 3.4B 3.45B 2.3B
Cost & Expenses
220.3B 219.87B 220.22B 222.44B 225.42B 219.43B 214.85B 209.5B 204.28B 198.04B 193.05B 187.87B 181.96B 177.32B 171.19B 165.86B 162B 155.99B 155.78B 154.1B
Income Tax Expense
532M 553M 476M 509M 352M 377M 494M 344M 376M 24M 1.08B 65M 163M 332M -601M 218M -289M -135M -328M -66M
Shares Outstanding (Basic)
239M 240M 242M 243M 244M 243M 245M 249M 254M 256M 261M 271M 273M 275M 279M 287M 290M 292M 294M 293M
Shares Outstanding (Diluted)
240M 241M 243M 245M 245M 245M 246M 250M 254M 258M 261M 273M 275M 275M 281M 289M 293M 294M 295M 293M
EPS (Basic)
6.47 6.43 5.39 5.24 3.55 2.34 2.62 0.62 1.01 1.77 -4.63 -3.96 -3.43 -3.54 1.92 3.89 2.09 3.94 4.73 3.34
EPS (Diluted)
6.45 6.41 5.38 5.23 3.55 2.34 2.61 0.61 0.99 1.74 -4.65 -3.98 -3.44 -3.54 1.91 3.87 2.07 3.90 4.69 3.31
EBITDA
3.11B 3.02B 2.62B 2.57B 1.95B 1.69B 1.89B 1.26B 1.42B 1.3B 631M -199M 72M 230M 832M 2.28B 1.29B 2.03B 2.11B 2.01B
EBIT
2.32B 2.25B 1.88B 1.85B 1.24B 988M 1.19B 563M 731M 601M -70M -894M -620M -463M 121M 1.53B 503M 1.2B 1.26B 1.13B
Depreciation & Amortization
790M 767M 737M 720M 710M 700M 698M 693M 692M 695M 701M 695M 692M 693M 711M 746M 783M 828M 853M 884M